Lipid 331 (solution in ethanol)
PG-20161-40674
Product information
- Catalog No.
- PG-20161-40674
- Product Name
- Lipid 331 (solution in ethanol)
- CAS No.
- Not specified
- Molecular Formula
- C61H107N3O6
- Molecular Weight
- 978.5
- Purity
- Not specified
- Storage
- -20°C
- Shipping
- Ambient Temperature
- Documents
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
Packaging & pricing
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-40674 | 1 MG | Inquiry | In stock | |
| PG-20161-40674 | 5 MG | Inquiry | In stock | |
| PG-20161-40674 | 10 MG | Inquiry | In stock |
Final pricing, package availability and delivery are confirmed with your quotation.
General Information
- Product Name
- Lipid 331 (solution in ethanol)
- CAS No.
- Not specified
- Synonyms
- Not specified
- Molecular Formula
- C61H107N3O6
- Molecular Weight
- 978.5
- Appearance
- Not specified
- Solubility
- Not specified
- Description
Lipid 331 (solution in ethanol) is a biodegradable cyclic ionizable cationic lipid with pKa = 7.53, used in lipid nanoparticle (LNP) formulations for in vitro and in vivo mRNA delivery research. LNPs containing this lipid and 5-methoxyuridine-modified ovalbumin mRNA activated interferon regulatory factor (IRF) in a THP-1 monocyte reporter assay.
In mice, intranasal LNP formulations combining lipid 331, DOTAP, and mRNA encoding a SARS-CoV-2 spike receptor-binding domain (RBD)–mouse complement C3d fusion significantly increased serum anti-RBD IgG titers. These findings concern specific experimental formulations rather than the lipid alone.